Tamsulosin Hydrochloride
Product Images NDC 43353-663

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 43353-663). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 0.4mg (43353 663)

Label for Tamsulosin HCl 0.4 mg capsules, containing 30 capsules per container. The label indicates the product is repackaged by Aphena Pharma Solutions - Tennessee, LLC, with original manufacturing by Rottendorf Pharma GmbH in Enningerloh, Germany. Storage instructions recommend maintaining temperature between 20-25 degrees Celsius. The label includes NDC 43353-0663-30 and states Rx only.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Ab8b786d-figure-01 (Ab8b786d Figure 01)

Chemical structure of Tamsulosin hydrochloride showing its molecular composition and arrangement, including aromatic rings, functional groups, and hydrochloride component, as depicted in the diagram.*

FDA Label Image

Ab8b786d-figure-02 (Ab8b786d Figure 02)

A line chart depicting plasma concentration (ng/mL) over time (hours) for Tamsulosin hydrochloride, comparing fasted versus fed conditions. The chart shows plasma concentration peaking higher and earlier under fasted conditions (dashed line) compared to fed conditions (solid line), with declining levels over a 36-hour period.*

FDA Label Image

Ab8b786d-figure-03 (Ab8b786d Figure 03)

A line graph showing mean change over a 13-week treatment duration with Tamsulosin hydrochloride at 0.8 mg and 0.4 mg doses compared to placebo. The x-axis represents the duration of treatment in weeks, and the y-axis shows mean change. Three distinct lines plot the mean change for the 0.8 mg dose, 0.4 mg dose, and placebo groups over time.*

FDA Label Image

Ab8b786d-figure-04 (Ab8b786d Figure 04)

Line graph showing mean change over duration of treatment in weeks for Tamsulosin hydrochloride 0.8 mg, 0.4 mg, and placebo groups. The y-axis represents mean change, and the x-axis shows treatment duration up to approximately 13 weeks and LOCF. Distinct markers differentiate the three groups, with sample sizes indicated below the x-axis.*

FDA Label Image

Ab8b786d-figure-05 (Ab8b786d Figure 05)

A line graph showing mean change in mL/sec over weeks of treatment comparing Tamsulosin hydrochloride at 0.8 mg and 0.4 mg doses versus placebo. The x-axis represents treatment duration in weeks, and the y-axis shows mean change. Both doses show higher mean change compared to placebo throughout the treatment period.*

FDA Label Image

Ab8b786d-figure-06 (Ab8b786d Figure 06)

A line chart showing the mean change in mL/sec over a 13-week treatment duration for Tamsulosin hydrochloride at doses of 0.4 mg and 0.8 mg compared to placebo. The x-axis represents weeks of treatment and the y-axis represents mean change in flow rate. Data points indicate greater improvement with both doses versus placebo over time.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.